Literature DB >> 18332166

Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.

Min Ji Kim1, Claude Jardel, Cyrille Barthélémy, Véronique Jan, Jean Philippe Bastard, Sandrine Fillaut-Chapin, Sydney Houry, Jacqueline Capeau, Anne Lombès.   

Abstract

Lipoatrophy is a prevalent side effect of antiretroviral treatment of human immunodeficiency virus (HIV) infection. Its mechanisms are still disputed but include mitochondrial toxicity and, in particular, mitochondrial DNA (mtDNA) depletion induced by nucleoside reverse transcriptase inhibitors. To obtain an integrated evaluation of the mitochondrial alteration in lipoatrophy, we investigated the DNA, RNA, and protein levels in 15 samples of abdominal subcutaneous adipose tissue from HIV-infected patients with peripheral lipoatrophy and compared the results with those for 15 samples from age- and body mass index-matched controls. The DNA and RNA analyses used PCR-based techniques, while proteins were quantified with enzyme-linked immunosorbent assay and measurement of activities with spectrophotometric assays. Depletion of mtDNA and mtDNA-encoded MT-CO2 mRNA was present, but normal levels of mtDNA-dependent activity (cytochrome c oxidase) and protein (MT-CO2p) showed that it was compensated for. An increase in nuclear-DNA-dependent mitochondrial activities (citrate synthase and malate dehydrogenase) and protein (COX4I1p), as well as transcriptional up-regulation of nuclear-DNA-encoded mitochondrial genes (COX4I1 and UCP2), demonstrated increased mitochondrial biogenesis. However, the expression of the known transcription factors of mitochondrial biogenesis (TFAM, NRF1, GABPA, PPARGC1A, PPARGC1B, and PPRC1) was normal or decreased. Increased amounts of activated caspase 3 and of DDIT3 mRNA showed the induction of apoptosis and oxidative stress, respectively. The mtDNA content did not correlate with any other mitochondrial parameter. In conclusion, mtDNA content does not appear to be an accurate biomarker of mitochondrial alteration in lipoatrophic adipose tissue. The preservation of mtDNA-dependent mitochondrial functions occurred despite severe mtDNA depletion. The presence of significant oxidative stress and apoptosis did not correlate with the mtDNA content.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332166      PMCID: PMC2346614          DOI: 10.1128/AAC.01449-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy.

Authors:  Josep Lloreta; Pere Domingo; Ramón M Pujol; Juan A Arroyo; Núria Baixeras; Xavier Matias-Guiu; Montserrat Gilaberte; Maria A Sambeat; Sergi Serrano
Journal:  Virchows Arch       Date:  2002-10-24       Impact factor: 4.064

2.  Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Authors:  David Nolan; Emma Hammond; Annalise Martin; Louise Taylor; Susan Herrmann; Elizabeth McKinnon; Cecily Metcalf; Bruce Latham; Simon Mallal
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

3.  Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.

Authors:  Véronique Joly; Philippe Flandre; Vincent Meiffredy; Nicolas Leturque; Marine Harel; Jean-Pierre Aboulker; Patrick Yeni
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

Review 4.  Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective.

Authors:  William Lewis; Brian J Day; William C Copeland
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

5.  Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy.

Authors:  Emma Hammond; David Nolan; Ian James; Cecily Metcalf; Simon Mallal
Journal:  AIDS       Date:  2004-03-26       Impact factor: 4.177

6.  Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.

Authors:  Craig S Pace; Annalise M Martin; Emma L Hammond; Cyril D Mamotte; David A Nolan; Simon A Mallal
Journal:  Antivir Ther       Date:  2003-08

7.  Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy.

Authors:  Katja Kannisto; Jussi Sutinen; Elena Korsheninnikova; Rachel M Fisher; Ewa Ehrenborg; Karl Gertow; Antti Virkamäki; Tuulikki Nyman; Hubert Vidal; Anders Hamsten; Hannele Yki-Järvinen
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

8.  Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

Authors:  David Nolan; Emma Hammond; Ian James; Elizabeth McKinnon; Simon Mallal
Journal:  Antivir Ther       Date:  2003-12

9.  The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction.

Authors:  Kalyankar Mahadev; Hiroyuki Motoshima; Xiangdong Wu; Jean Marie Ruddy; Rebecca S Arnold; Guangjie Cheng; J David Lambeth; Barry J Goldstein
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy.

Authors:  Grace McComsey; Jen-Fue Maa
Journal:  AIDS Read       Date:  2003-11
View more
  11 in total

1.  Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing.

Authors:  Juan R Peinado; Pedro M Quirós; Marina R Pulido; Guillermo Mariño; Maria L Martínez-Chantar; Rafael Vázquez-Martínez; José M P Freije; Carlos López-Otín; María M Malagón
Journal:  Mol Cell Proteomics       Date:  2011-08-09       Impact factor: 5.911

2.  Tenofovir nephrotoxicity: 2011 update.

Authors:  Beatriz Fernandez-Fernandez; Ana Montoya-Ferrer; Ana B Sanz; Maria D Sanchez-Niño; Maria C Izquierdo; Jonay Poveda; Valeria Sainz-Prestel; Natalia Ortiz-Martin; Alejandro Parra-Rodriguez; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  AIDS Res Treat       Date:  2011-06-07

3.  Thymidine kinase 2 deficiency-induced mitochondrial DNA depletion causes abnormal development of adipose tissues and adipokine levels in mice.

Authors:  Joan Villarroya; Beatriz Dorado; Maya R Vilà; Elena Garcia-Arumí; Pere Domingo; Marta Giralt; Michio Hirano; Francesc Villarroya
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

4.  Xenobiotics that affect oxidative phosphorylation alter differentiation of human adipose-derived stem cells at concentrations that are found in human blood.

Authors:  Laura Llobet; Janne M Toivonen; Julio Montoya; Eduardo Ruiz-Pesini; Ester López-Gallardo
Journal:  Dis Model Mech       Date:  2015-09-17       Impact factor: 5.758

5.  Mitochondrial DNA copy number variation across human cancers.

Authors:  Ed Reznik; Martin L Miller; Yasin Şenbabaoğlu; Nadeem Riaz; Judy Sarungbam; Satish K Tickoo; Hikmat A Al-Ahmadie; William Lee; Venkatraman E Seshan; A Ari Hakimi; Chris Sander
Journal:  Elife       Date:  2016-02-22       Impact factor: 8.140

6.  Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.

Authors:  Lucie Duluc; Blerina Ahmetaj-Shala; Jane Mitchell; Vahitha B Abdul-Salam; Abdul S Mahomed; Lulwah Aldabbous; Eduardo Oliver; Lucio Iannone; Olivier D Dubois; Elisabeth M Storck; Edward W Tate; Lan Zhao; Martin R Wilkins; Beata Wojciak-Stothard
Journal:  Cardiovasc Res       Date:  2017-03-01       Impact factor: 10.787

Review 7.  Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome.

Authors:  P Pérez-Matute; L Pérez-Martínez; J R Blanco; J A Oteo
Journal:  Oxid Med Cell Longev       Date:  2013-07-21       Impact factor: 6.543

8.  QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease.

Authors:  Virginia Guarani; Claude Jardel; Dominique Chrétien; Anne Lombès; Paule Bénit; Clémence Labasse; Emmanuelle Lacène; Agnès Bourillon; Apolline Imbard; Jean-François Benoist; Imen Dorboz; Mylène Gilleron; Eric S Goetzman; Pauline Gaignard; Abdelhamid Slama; Monique Elmaleh-Bergès; Norma B Romero; Pierre Rustin; Hélène Ogier de Baulny; Joao A Paulo; J Wade Harper; Manuel Schiff
Journal:  Elife       Date:  2016-09-13       Impact factor: 8.140

9.  Improved adipose tissue function with initiation of protease inhibitor-only ART.

Authors:  Robert T Maughan; Eoin R Feeney; Emilie Capel; Jacqueline Capeau; Pere Domingo; Marta Giralt; Joep M A Lange; Praphan Phanuphak; David A Cooper; Peter Reiss; Patrick W G Mallon
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

10.  Combined pharmacological activation of AMPK and PPARδ potentiates the effects of exercise in trained mice.

Authors:  Mark Christian C Manio; Kazuo Inoue; Mina Fujitani; Shigenobu Matsumura; Tohru Fushiki
Journal:  Physiol Rep       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.